Agilent Technologies Inc (NYSE:A) was the recipient of unusually large options trading activity on Monday. Stock investors bought 77,934 put options on the stock. This is an increase of 1,169% compared to the average volume of 6,142 put options.

A number of brokerages have recently issued reports on A. Cowen reaffirmed a “hold” rating and issued a $70.00 target price on shares of Agilent Technologies in a report on Wednesday, November 22nd. Evercore ISI began coverage on shares of Agilent Technologies in a report on Wednesday, January 3rd. They issued an “outperform” rating and a $75.00 target price on the stock. Robert W. Baird reaffirmed a “buy” rating and issued a $72.00 target price on shares of Agilent Technologies in a report on Friday, November 24th. Zacks Investment Research raised shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $76.00 target price on the stock in a report on Tuesday, October 31st. Finally, JPMorgan Chase & Co. upped their target price on shares of Agilent Technologies to $75.00 and gave the company an “overweight” rating in a report on Tuesday, November 21st. Six analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $69.25.

In other news, VP Mark Doak sold 4,154 shares of the company’s stock in a transaction dated Tuesday, December 5th. The shares were sold at an average price of $67.00, for a total value of $278,318.00. Following the sale, the vice president now directly owns 68,270 shares of the company’s stock, valued at approximately $4,574,090. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CFO Didier Hirsch sold 12,964 shares of the company’s stock in a transaction dated Wednesday, November 22nd. The shares were sold at an average price of $69.00, for a total transaction of $894,516.00. Following the completion of the sale, the chief financial officer now directly owns 184,851 shares in the company, valued at $12,754,719. The disclosure for this sale can be found here. Insiders have sold a total of 219,991 shares of company stock worth $15,468,795 over the last three months.

A number of institutional investors and hedge funds have recently made changes to their positions in A. Dupont Capital Management Corp acquired a new position in shares of Agilent Technologies during the 3rd quarter worth approximately $101,000. Front Row Advisors LLC acquired a new position in shares of Agilent Technologies during the 4th quarter worth approximately $106,000. AMG National Trust Bank acquired a new position in shares of Agilent Technologies during the 4th quarter worth approximately $201,000. Premia Global Advisors LLC acquired a new position in shares of Agilent Technologies during the 4th quarter worth approximately $204,000. Finally, Prudential PLC acquired a new position in shares of Agilent Technologies during the 2nd quarter worth approximately $211,000.

Shares of Agilent Technologies (NYSE:A) traded up $1.36 on Wednesday, reaching $69.70. 3,640,000 shares of the company were exchanged, compared to its average volume of 2,210,000. Agilent Technologies has a twelve month low of $50.09 and a twelve month high of $75.00. The firm has a market cap of $22,510.00, a price-to-earnings ratio of 33.35, a P/E/G ratio of 2.07 and a beta of 1.28. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.85 and a current ratio of 3.30.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Monday, November 20th. The medical research company reported $0.67 EPS for the quarter, beating the Zacks’ consensus estimate of $0.62 by $0.05. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.95%. The business had revenue of $1.19 billion for the quarter, compared to analyst estimates of $1.17 billion. During the same quarter in the prior year, the business earned $0.59 EPS. Agilent Technologies’s quarterly revenue was up 7.0% on a year-over-year basis. analysts anticipate that Agilent Technologies will post 2.58 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This piece of content was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2018/02/14/agilent-technologies-target-of-unusually-large-options-trading-a.html.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.